Latest Articles
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials - Stock Titan
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials Stock Titan
Published: Aug. 13, 2025, 8:15 p.m.
GnRH Receptor Antagonists Market Poised for Significant - openPR.com
GnRH Receptor Antagonists Market Poised for Significant openPR.com
Published: Aug. 13, 2025, 7:52 p.m.
Le Wand just made luxury vibrators more affordable than ever - Mashable
Le Wand just made luxury vibrators more affordable than ever Mashable
Published: Aug. 13, 2025, 4:57 p.m.
Unavoidable forever chemicals may be associated with severe endometriosis - Medical Xpress
Unavoidable forever chemicals may be associated with severe endometriosis Medical Xpress
Published: Aug. 13, 2025, 2:46 p.m.
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis - Nature
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis Nature
Published: Aug. 13, 2025, 2:22 p.m.
Q&A: Endometrial Cancer - Medscape
Q&A: Endometrial Cancer Medscape
Published: Aug. 13, 2025, 2:13 p.m.
Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy - Cureus
Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy Cureus
Published: Aug. 13, 2025, 1:15 p.m.
UK MHRA highlights potential of the vaginal microbiome in women’s health - BioWorld MedTech
UK MHRA highlights potential of the vaginal microbiome in women’s health BioWorld MedTech
Published: Aug. 13, 2025, 1 p.m.
Link copied to clipboard!